Alacizumab (Anti-VEGFR2 / KDR / CD309)
A3109
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameAlacizumab (Anti-VEGFR2 / KDR / CD309)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionAlacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
- Storage Instruction-20°C
- UNSPSC12352203